A2-Ai
Home
LeadershipBlogCareersGet in touch
Home
LeadershipBlogCareersGet in touch
All posts Tag / Simulations

Categories

blogcase studiesnewsproductsresearch spotlightsservicestoolingupdates

Tags

2025ADaMADMEAgingAIAnimal Modelsanimal testingAnnualapproval processbetween-subject variabilityCardiac Safetycdisc
RSS See all filters
newest
servicescase studies

Accelerating FDA Approval with MIDD: How A2-Ai Secured a New Dose Without a Phase 3 Trial

Eric Storms November 14, 2025

Links

HomeLeadershipBlogCareersContact

Solutions

A2-Ai CloudAlexandriaPRISMSage AI

Science Services

EducationFDA Project OptimusClinical PharmacologyPharmacometricsPreclinical Support

Technology Services

Technology

Calculators

Exposure-Response ThresholdsMulti-compartment PK Parameter Conversion

Resources

Attributions
A2-Ai

2723 S. State Street
Suite 310
Ann Arbor, MI 48104

© 2026 A2-Ai LLC. All rights reserved.